Twycross R , Wilcock A.Symptom management in ad-vanced cancer, third edition. Radcliffe Medical Press , 2001.
2.
Simpson GM , Amuso D , Blair JH , et al.Phenothiazine-produced extrapyramidal system disturbance . Arch Gen Psychiatry1964; 10: 199-208 .
3.
Buttner MD , Walder B , von Elm E , et al.Is low-dose haloperidol a useful antiemetic?: a meta-analysis of published and unpublished randomized trials . Anesthesiology2004; 101: 1454-1463 .
4.
Kudo S , Ishizaki T.Pharmacokinetics of haloperidol an update . Clin Pharmacokinet1999; 37: 435-456 .
5.
de Leon J , Diaz FJ , Wedlund P , et al.Haloperidol half-life after chronic dosing . J Clin Psychopharmacol2004; 24: 656-660 .
6.
Kornhuber J , Schultz A , Wiltfang J , et al.Persistence of haloperidol in human brain tissue . Am J Psychiatry1999; 156: 885-890 .
7.
Vella-Brincat J , Macleod AD.Haloperidol in palliative care . Palliat Med2004; 18: 195-201 .